A premature boy with a congenital form of nemaline myopathy due to mutation in the
ACTA1-gene showed decreased carnitine levels in the eighth week of life. After sufficient
oral carnitine substitution he improved gradually. In the first 15 months of life
he made good progress; he reached full head control, learned to sit unsupported and
was able to raise objects. At that time the carnitine levels were normal without substitution.
Nemaline myopathy is clinically and genetically heterogenous. The pathogenesis of
the muscle weakness is poorly understood. Disturbances of carnitine metabolism in
this group of patients as one possibility are conceivable. Further investigations
of carnitine metabolism in patients with nemaline myopathy may shed light on the pathogenesis
of this entity.
Nemaline myopathy - Carnitine insufficiency - Carnitine substitution - Floppy infant
- ACTA1 gene mutation